Bristol-Myers Squibb Co. (BMY)
NYSE: BMY · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 1994
Grade6.4
◀ Past 7.7● Present 6.6▶ Future 4.9
Who owns Bristol-Myers Squibb Co.
As filed with the SECHolders of 5% or more
3
Vanguard Capital Management holds 7.49% of Common Stock, as its SCHEDULE 13G filed Apr 29, 2026 says.
Directors and officers
24
report now, of 61 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK
JPMorgan Chase & Co.
SCHEDULE 13G/A · filed Oct 31, 2025 · Common Stock, $0.10 Par Value · reported falling below 5%, from 5.1% in Apr 25, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What BMY reports owning in othersstakes of 5% or more, and other ties
Compugen Ltd. CGEN
SCHEDULE 13G/A · filed Feb 14, 2025 · Ordinary Shares, par value NIS 0.01 · reported falling below 5%
Celularity Inc. CELU
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common stock, par value $0.0001 per share · reported falling below 5%
Q32 Bio Inc. QTTB
SCHEDULE 13G/A · filed Feb 14, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%
234 subsidiaries in 52 countries, from the list filed with the 10-K filed Feb 11, 2026.
Insider tradesForm 4
5sales
0purchases
0sales on a scheduled plan
4people selling
$2.5Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 6, 2025 to Nov 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 61 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Elkins David V | EVP, Chief Financial Officer | 2 | $1.9M | 0 | 0 | $0 |
| Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | 1 | $400,000 | 0 | 0 | $0 |
| Haller Julia A | director | 1 | $200,000 | 0 | 0 | $0 |
| Holzer Phil M | SVP and Controller | 1 | $0 | 0 | 0 | $0 |